Skip to Content
Merck
  • Granulocytic sarcoma presenting with lymph node infarction at disease onset.

Granulocytic sarcoma presenting with lymph node infarction at disease onset.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (2003-12-18)
Masaru Kojima, Shigeo Nakamura, Kazuhiko Shimizu, Yuko Yamane, Hideaki Itoh, Nobuhide Masawa
ABSTRACT

A completely infarcted lymph node is an unusual event. However, lymph node infarction should alert the pathologist to the considerable likelihood of malignant lymphoma. We report two unusual cases of acute myeloid leukemia presenting with granulocytic sarcoma at disease onset with a lymph node lesion exhibiting extensive lymph node infarction. The infarcted tissue contained numerous eosinophilic cell ghosts. There were some islands of degenerated, pyknotic medium-sized nuclei resembling lymphoblasts present in the necrotic area. By immunohistochemistry, these medium sized cells were CD3-, CD20-, CD34+, CD43+, CD45RO-, CD68-, CD79a- and myeloperoxidase+ in both cases. Differentiation of granulocytic sarcoma from malignant lymphomas is important for adequate therapy. The present cases indicate that granulocytic sarcoma should be added to the list of differential diagnoses for lymph node infarction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Myeloperoxidase (EP151) Rabbit Monoclonal Primary Antibody